Small vessel remodeling and impaired endothelial- dependent dilatation in subcutaneous resistance arteries from patients with acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 4, 2009, Pages 1111-1117

  Paisley, Angela N ^a   Izzard, Ashley S ^b   Gemmell, Islay ^c   Cruickshank, Kennedy ^b   Trainer, Peter J ^a   Heagerty, Anthony M ^b,c  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; INDOMETACIN; N NITRO LEVO ARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PEGVISOMANT; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ACROMEGALY; ADULT; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; CAPILLARY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; MALE; MYOGRAPHY; PRIORITY JOURNAL; SMOOTH MUSCLE CONTRACTILITY; TISSUE REGENERATION; VASCULAR SMOOTH MUSCLE;

EID: 65249113946     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0948     Document Type: Article

References (40)

1. Colao A, Ferone D, Marzullo P, Lombardi G 2004 Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25: 102-152
2. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK 1994 Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102
3. Fazio S, Cittadini A, Sabatini D, Merola B, Colao AM, Biondi B, Lombardi G, Sacca L 1993 Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J 14:26-33
4. Lie JT 1980 Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J 100:41-52
5. Capaldo B, Guardasole V, Pardo F, Matarazzo M, DiRella F, Numis F, Merola B, Longobardi S, Sacca L 2001 Abnormal vascular reactivity in growth hormone deficiency. Circulation 103:520-524
6. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF 1999 Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clin Endocrinol (Oxf) 50:457-464
7. Pfeifer M, Verhovec R, Zizek B 1999 Growth hormone (GH) and atherosclerosis: changes in morphology and function of major arteries during GH treatment. Growth Horm IGF Res 9(Suppl A):25-30
8. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D, Bardsley B 1997 Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 81:228-233
9. Frystyk J, Skjaerbaek C, Alexander N, Emanuelsson H, Suryapranata H, Beyer H, Foegh M, Orskov H 1996 Lanreotide reduces serum free and total insulinlike growth factor-I after angioplasty. Circulation 94:2465-2471
10. Kambayashi Y, Nagata K, Ichiki T, Inagami T 1996 Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular- smooth-muscle cells. Eur J Biochem 239:558 -565
11. Hu ZW, Shi XY, Hoffman BB 1996 Insulin and insulin-like growth factor I differentially induce α1-adrenergic receptor subtype expression in rat vascular smooth muscle cells. J Clin Invest 98:1826-1834
12. Haylor J, Singh I, el Nahas AM 1991 Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 39:333-335
13. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, Di Somma C, Assanti AP, Lombardi G 2001 Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol (Oxf) 54:515-524
14. Brevetti G, Marzullo P, Silvestro A, Pivonello R, Oliva G, di Somma C, Lombardi G, Colao A 2002 Early vascular alterations in acromegaly. J Clin Endocrinol Metab 87:3174-3179
15. Otsuki M, Kasayama S, Yamamoto H, Saito H, Sumitani S, Kouhara H, Saitoh Y, Ohnishi T, Arita N 2001 Characterization of premature atherosclerosis of carotid arteries in acromegalic patients. Clin Endocrinol (Oxf) 54:791-796
16. Harrison BD, Millhouse KA, Harrington M, Nabarro JD 1978 Lung function in acromegaly. Q J Med 47:517-532
17. Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P, Laine H, Nuutila P, Salmela P, Salmi J, Stenman UH, Viikari J, Voutilainen E 2005 A nationwide survey of mortality in acromegaly. JClin Endocrinol Metab 90:40814086
18. Christensen KL, Mulvany MJ 2001 Location of resistance arteries. J Vasc Res 38:1-12
19. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ 1993 Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 21:391-397
20. Abdu TA, Elhadd T, Pfeifer M, Clayton RN 2001 Endothelial dysfunction in endocrine disease. Trends Endocrinol Metab 12:257-265
21. Rizzoni D, Porteri E, Giustina A, De Ciuceis C, SleimanI, BoariGE, Castellano M, Muiesan ML, Bonadonna S, Burattin A, Cerudelli B, Agabiti-Rosei E 2004 Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. Hypertension 43:561-565
22. Halpern W, Osol G, Coy GS 1984 Mechanical behavior of pressurized in vitro prearteriolar vessels determined with a video system. Ann Biomed Eng 12: 463-479
23. Schofield I, Malik R, Izzard A, Austin C, Heagerty A 2002 Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106:3037-3043
24. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthen L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P 2003 Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53-60
25. Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, HaydenD, Klibanski A 2002 Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. J Clin Endocrinol Metab 87:1692-1699
26. Parkinson C, Drake WM, Wieringa G, Yates AP, Besser GM, Trainer PJ 2002 Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly. Clin Endocrinol (Oxf) 56:303-311
27. Mulvany MJ 2002 Small artery remodeling and significance in the development of hypertension. News Physiol Sci 17:105-109
28. Rizzoni D, Porteri E,Guelfi D, Muiesan ML,Valentini U, Cimino A,Girelli A, Rodella L, Bianchi R, Sleiman I, Rosei EA 2001 Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non- insulin-dependent diabetes mellitus. Circulation 103:1238-1244
29. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E 2003 Prognostic significance of small-artery structure in hypertension. Circulation 108:2230 -2235
30. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL 2007 Small artery structure is an independent predictor of cardiovascular events in essential hypertension. JHypertens 25:1021-1026
31. Bollano E, Omerovic E, Bohlooly-y M, Kujacic V, Madhu B, Tornell J, Isaksson O, Soussi B, Schulze W, FuM L, Matejka G, Waagstein F, Isgaard J 2000 Impair- ment of cardiacfunction and bioenergetics in adulttransgenic mice overexpressing the bovine growth hormone gene. Endocrinology 141:2229-2235
32. Dilley RJ, Schwartz SM 1989 Vascular remodeling in the growth hormone transgenic mouse. Circ Res 65:1233-1240
33. Bohlooly YM, Carlson L, Olsson B, Gustafsson H, Andersson IJ, Tornell J, Bergstrom G 2001 Vascular function and blood pressure in GH transgenic mice. Endocrinology 142:3317-3323
34. King GL, Goodman AD, Buzney S, Moses A, Kahn CR 1985 Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028 -1036
35. Chen Y, Capron L, Magnusson JO, Wallby LA, Arnqvist HJ 1998 Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo. Growth Horm IGF Res 8:299-303
36. Swearingen B, Barker 2nd FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphen oidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
37. Buus NH, Simonsen U, Pilegaard HK, Mulvany MJ 2000 Nitric oxide, prostanoid and non-NO, non-prostanoid involvement in acetylcholine relaxation of isolated human small arteries. Br J Pharmacol 129:184-192
38. Vettoretti S, Ochodnicky P, Buikema H, Henning RH, Kluppel CA, de Zeeuw D, van Dokkum RP 2006 Altered myogenic constriction and endothelium- derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensivesubtotally nephrectomized rats. J Hypertens 24:2215-2223
39. Goode GK, Heagerty AM 1995 In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. Circulation 91:2898 - 2903
40. Vitale G, Pivonello R, Lombardi G, Colao A 2004 Cardiovascular complications in acromegaly. Minerva Endocrinol 29:77-88